85 Oral etoposide (VP) and oral cyclophosphamide (CP) for poor prognosis extensive disease (ED) small cell lung cancer (SCLC). A southwest oncology group clinical and pharmacokinetic study

✍ Scribed by Grunberg, S.M.; Rector, D.; Hande, K.; Livingston, R.

• Book ID: 122757722
• Publisher: Elsevier Science
• Year: 1997
• Tongue: English
• Weight: 290 KB
• Volume: 18
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/S0169-5002(97)89364-6